BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paul S, Bravo Vázquez LA, Reyes-Pérez PR, Estrada-Meza C, Aponte Alburquerque RA, Pathak S, Banerjee A, Bandyopadhyay A, Chakraborty S, Srivastava A. The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review. Virus Res 2022;308:198631. [PMID: 34788642 DOI: 10.1016/j.virusres.2021.198631] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 29.0] [Reference Citation Analysis]
Number Citing Articles
1 Arman K, Dalloul Z, Bozgeyik E. Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics. Gene 2023;861:147232. [PMID: 36736508 DOI: 10.1016/j.gene.2023.147232] [Reference Citation Analysis]
2 Bravo-Vázquez LA, Medina-Ríos I, Márquez-Gallardo LD, Reyes-Muñoz J, Serrano-Cano FI, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review. Dig Dis Sci 2023;68:38-53. [PMID: 35507132 DOI: 10.1007/s10620-022-07516-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Demongeot J, Fougère C. mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation. Vaccines (Basel) 2022;11. [PMID: 36679885 DOI: 10.3390/vaccines11010040] [Reference Citation Analysis]
4 Ogunmwonyi I, Adebajo A, Wilkinson JM. The genetic and epigenetic contributions to the development of nutritional rickets. Front Endocrinol (Lausanne) 2022;13:1059034. [PMID: 36619587 DOI: 10.3389/fendo.2022.1059034] [Reference Citation Analysis]
5 Kim IS, Lee SG, Shin SG, Jeong H, Sohn KM, Park KS, Silwal P, Cheon S, Kim J, Kym S, Kim YS, Jo EK, Park C. Dysregulated thrombospondin 1 and miRNA-29a-3p in severe COVID-19. Sci Rep 2022;12:21227. [PMID: 36481664 DOI: 10.1038/s41598-022-23533-x] [Reference Citation Analysis]
6 Periwal N, Bhardwaj U, Sarma S, Arora P, Sood V. In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs. Front Cell Infect Microbiol 2022;12:966870. [PMID: 36519126 DOI: 10.3389/fcimb.2022.966870] [Reference Citation Analysis]
7 Kanapeckaitė A, Mažeikienė A, Geris L, Burokienė N, Cottrell GS, Widera D. Computational pharmacology: New avenues for COVID-19 therapeutics search and better preparedness for future pandemic crises. Biophys Chem 2022;290:106891. [PMID: 36137310 DOI: 10.1016/j.bpc.2022.106891] [Reference Citation Analysis]
8 Bravo-Vázquez LA, Frías-Reid N, Ramos-Delgado AG, Osorio-Pérez SM, Zlotnik-Chávez HR, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Transl Oncol 2022;27:101579. [PMID: 36332600 DOI: 10.1016/j.tranon.2022.101579] [Reference Citation Analysis]
9 Arisan ED, Dart DA, Grant GH, Dalby A, Kancagi DD, Turan RD, Yurtsever B, Karakus GS, Ovali E, Lange S, Uysal-onganer P. microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model. ACS Omega. [DOI: 10.1021/acsomega.2c05245] [Reference Citation Analysis]
10 Sun G, Cui Q, Garcia G, Lizhar EM, Arumugaswami V, Shi Y, Riggs AD. Viral and Host Small RNA Response to SARS-CoV-2 Infection. Microbiology Research 2022;13:788-808. [DOI: 10.3390/microbiolres13040056] [Reference Citation Analysis]
11 Najafipour R, Mohammadi D, Estaki Z, Zarabadi K, Jalilvand M, Moghbelinejad S. Screening for differentially expressed microRNAs in BALF and blood samples of infected COVID-19 ARDS patients by small RNA deep sequencing. J Clin Lab Anal 2022;:e24672. [PMID: 36166345 DOI: 10.1002/jcla.24672] [Reference Citation Analysis]
12 Latini A, Vancheri C, Amati F, Morini E, Grelli S, Claudia M, Vita P, Colona VL, Murdocca M, Andreoni M, Malagnino V, Raponi M, Cocciadiferro D, Novelli A, Borgiani P, Novelli G. Expression analysis of miRNA hsa-let7b-5p in naso-oropharyngeal swabs of COVID-19 patients supports its role in regulating ACE2 and DPP4 receptors. J Cell Mol Med 2022. [PMID: 36073344 DOI: 10.1111/jcmm.17492] [Reference Citation Analysis]
13 Ruiz-manriquez LM, Carrasco-morales O, Sanchez Z EA, Osorio-perez SM, Estrada-meza C, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNA-mediated regulation of key signaling pathways in hepatocellular carcinoma: A mechanistic insight. Front Genet 2022;13:910733. [DOI: 10.3389/fgene.2022.910733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mohamed Y, El-maradny YA, Saleh AK, Nayl AA, El-gendi H, El-fakharany EM. A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment. Biomedicine & Pharmacotherapy 2022;153:113499. [DOI: 10.1016/j.biopha.2022.113499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Roustai Geraylow K, Hemmati R, Kadkhoda S, Ghafouri-fard S. miRNA expression in COVID-19. Gene Reports 2022;28:101641. [DOI: 10.1016/j.genrep.2022.101641] [Reference Citation Analysis]
16 Moatar AI, Chis AR, Marian C, Sirbu I. Gene Network Analysis of the Transcriptome Impact of SARS-CoV-2 Interacting MicroRNAs in COVID-19 Disease. IJMS 2022;23:9239. [DOI: 10.3390/ijms23169239] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Dias TR, Dias F, Teixeira AL, Sousa H, Oliveira J, Medeiros R. MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 2022;11:2279. [DOI: 10.3390/cells11152279] [Reference Citation Analysis]
18 Rasmi Y, Hatamkhani S, Naderi R, Shokati A, Nayeb Zadeh V, Hosseinzadeh F, Farnamian Y, Jalali L. Molecular signaling pathways, pathophysiological features in various organs, and treatment strategies in SARS-CoV2 infection. Acta Histochem 2022;124:151908. [PMID: 35662001 DOI: 10.1016/j.acthis.2022.151908] [Reference Citation Analysis]
19 Sagulkoo P, Chuntakaruk H, Rungrotmongkol T, Suratanee A, Plaimas K. Multi-Level Biological Network Analysis and Drug Repurposing Based on Leukocyte Transcriptomics in Severe COVID-19: In Silico Systems Biology to Precision Medicine. JPM 2022;12:1030. [DOI: 10.3390/jpm12071030] [Reference Citation Analysis]
20 Bueno LCM, Paim LR, Minin EOZ, da Silva LM, Mendes PR, Kiyota TA, Schreiber AZ, Bombassaro B, Mansour E, Moretti ML, Chow JT, Salmena L, Coelho-filho OR, Velloso LA, Nadruz W, Schreiber R. Increased Serum Mir-150-3p Expression Is Associated with Radiological Lung Injury Improvement in Patients with COVID-19. Viruses 2022;14:1363. [DOI: 10.3390/v14071363] [Reference Citation Analysis]
21 Ward B, Yombi JC, Balligand J, Cani PD, Collet J, de Greef J, Dewulf JP, Gatto L, Haufroid V, Jodogne S, Kabamba B, Pyr dit Ruys S, Vertommen D, Elens L, Belkhir L. HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach. Viruses 2022;14:1373. [DOI: 10.3390/v14071373] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Ahmed JQ, Maulud SQ, Dhawan M, Priyanka, Choudhary OP, Jalal PJ, Ali RK, Tayib GA, Hasan DA. MicroRNAs in the development of potential therapeutic targets against COVID-19: A narrative review. J Infect Public Health 2022;15:788-99. [PMID: 35751930 DOI: 10.1016/j.jiph.2022.06.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ita K. Advances in the delivery of COVID-19 vaccines. AJBPS 2022;2:5. [DOI: 10.25259/ajbps_3_2022] [Reference Citation Analysis]
24 Jothimani G, Bhatiya M, Pathak S, Paul S, Banerjee A. Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review. Recent Adv Inflamm Allergy Drug Discov 2022;16:5-15. [PMID: 35670340 DOI: 10.2174/2772270816666220606112727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Elemam NM, Hasswan H, Aljaibeji H, Sharif-askari NS, Halwani R, Taneera J, Sulaiman N. Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients. Life 2022;12:575. [DOI: 10.3390/life12040575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
26 Giuliani A, Matacchione G, Ramini D, Di Rosa M, Bonfigli AR, Sabbatinelli J, Monsurrò V, Recchioni R, Marcheselli F, Marchegiani F, Piacenza F, Cardelli M, Galeazzi R, Pomponio G, Ferrarini A, Gabrielli A, Svegliati Baroni S, Moretti M, Sarzani R, Giordano P, Cherubini A, Corsonello A, Antonicelli R, Procopio AD, Ferracin M, Bonafè M, Lattanzio F, Olivieri F. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality. Mechanisms of Ageing and Development 2022;202:111636. [DOI: 10.1016/j.mad.2022.111636] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
27 Ruiz-manriquez LM, Ledesma Pacheco SJ, Medina-gomez D, Uriostegui-pena AG, Estrada-meza C, Bandyopadhyay A, Pathak S, Banerjee A, Chakraborty S, Srivastava A, Paul S. A Brief Review on the Regulatory Roles of MicroRNAs in Cystic Diseases and Their Use as Potential Biomarkers. Genes 2022;13:191. [DOI: 10.3390/genes13020191] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Suvarnapathaki S, Chauhan D, Nguyen A, Ramalingam M, Camci-Unal G. Advances in Targeting ACE2 for Developing COVID-19 Therapeutics. Ann Biomed Eng 2022;50:1734-49. [PMID: 36261668 DOI: 10.1007/s10439-022-03094-w] [Reference Citation Analysis]
29 Bravo Vázquez LA, Moreno Becerril MY, Mora Hernández EO, León Carmona GG, Aguirre Padilla ME, Chakraborty S, Bandyopadhyay A, Paul S. The Emerging Role of MicroRNAs in Bone Diseases and Their Therapeutic Potential. Molecules 2021;27:211. [PMID: 35011442 DOI: 10.3390/molecules27010211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]